I migliori medici di Chemioterapia Intraperitoneale Ipertermica (HIPEC) in Israele — TOP-10 medici

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, specializzata in trattamenti complessi per il cancro.

• Più di 25 anni di esperienza in oncologia
• Fellowship in sarcoma dei tessuti molli e delle ossa presso l'Institut Gustave Roussy
• Membro della facoltà del gruppo di sarcoma dell'ESMO
• Ha pubblicato ampie ricerche sui trattamenti per il cancro

La Dott.ssa Sharon Pelles è specializzata in HIPEC presso il Sourasky Medical Center, portando un'ampia esperienza nei trattamenti avanzati contro il cancro.

• Conduce ricerche cliniche sui trattamenti oncologici
• Offre una vasta gamma di interventi chirurgici e terapie per il cancro
• Esperta in procedure complesse come l'operazione di Whipple
• Fornisce piani di trattamento personalizzati per ciascun paziente

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Direttore della Divisione di Oncologia Medica presso il Sourasky Medical Center – Il Dr. Wolf guida un team di eccellenza specializzato in trattamenti oncologici avanzati.

• Formazione presso l'Università Ben Gurion del Negev
• Esperienza approfondita in oncologia e medicina interna
• Collabora strettamente con unità mediche militari per cure specialistiche

Leader dell'Iniziativa Nazionale di Medicina Genomica di Israele – Il Dr. Raphael è specializzato in oncologia di precisione presso il Sourasky Medical Center.

• Docente senior presso la facoltà di medicina dell'Università di Tel Aviv
• Ricercatore principale per diversi studi clinici sull'immunoterapia
• Membro del consiglio della Società Israeliana di Oncologia Acuta
• Membro di ESMO e IASLC con focus sull'oncologia toracica

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.